Rare blood disease improves the defence against germs

Researchers of the HZI and of the University of Magdeburg find increased immune reaction associated with a rare bone marrow disease Patients afflicted by myeloproliferative neoplasia – a group of chronic malignant bone marrow diseases – bear a mutation in their haematopoietic stem cells. The mutation leads to the bone marrow producing too many blood cells, which thickens the blood.